Wirelessly programmable optical stimulation system for optogenetics

来源 :The 6th FAONS Congress and 11th Biennial Conference of CNS(第 | 被引量 : 0次 | 上传用户:yuming_wu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objectives: Optogenetics technology are able to conduct neuromodulation with high selectivity and high spatiotemporal resolution.
其他文献
Introduction Microglial activation contributes to neuroinflammation and neuronal damages in neurodegenerative disorders including Alzheimers and Parkinsons diseases.
Alzheimers disease(AD)is an age-related neurodegenerative disorder,and characterized by chronic progressive deterioration of cognition,learning and memory.
Beta-amyloid(Aβ)cascade theory is the most recognized pathogenesis of Alzheimers disease(AD).
Precious studies have demonstrated that estrogen affects iron metabolism in peripheral tissues.
Alzheimers disease(AD)is a degenerative disorder of the central nervous system,which often impairs learning and memory,emotion and cognitive function.
Abnormal α-synuclein(α-syn)expression and aggregation have been implicated in the pathogenesis of Parkinsons disease(PD),dementia with Lewy bodies(DLB),and Alzheimers disease(AD).
会议
Aging is associated with an increased risk for Parkinsons disease(PD)and dementia with Lewy bodies(DLB),in which alpha-synuclein(α-syn)oligomerization plays key pathogenic roles.
Objective Alzheimer disease(AD)is a fatal neurodegenerative disorder characterized by progressive cognitive impairment and memory loss.